Episodios

  • Promoting gender equity in academic rheumatology
    Feb 21 2023
    In this podcast, Dr. Javier Rodríguez-Carrio talks to Dr. Pavel Ovseiko and Prof. Laura Coates about the recent paper on gender equity in academic rheumatology which emerged from a EULAR task force. They discuss the current situation of gender equity in academic rheumatology across Europe, the pros and cons of potential interventions to accelerate gender-equitable career advancement in this field and how and these be applied in the short- and long-term. Link to the viewpoint: https://rmdopen.bmj.com/content/8/2/e002518.long

    Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864

    Más Menos
    29 m
  • Autoantibodies against PTM proteins as biomarkers for lupus
    Jan 13 2023
    Autoantibodies against post-translationally modified proteins (PTM) are described in various rheumatic diseases and facilitate diagnosis and patient stratification. Researchers from the Leiden University Medical Center analysed the presence of autoantibodies against six different post-translational modifications in a cohort of patients with neuropsychiatric lupus. In this podcast, Leendert Trouw, Rory Monahan and Michelle van den Beukel discuss the results of their study with the ARD/RMDopen social media advisor Caroline Ospelt. Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002079

    Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864

    Más Menos
    10 m
  • Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study
    Jul 15 2022
    In this podcast, Dr. Javier Rodríguez-Carrio (1) talks to Dr. Tue Kragstrup (2) about the recent safety data on JAK inhibitors emerged after the ORAL Surveillance study. They discuss what is the current situation, the potential strategies to escape a ‘static’ situation, by managing uncertainty in the context of balancing risks, patient preferences and shared-decision process. Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002236

    (1) Javier Rodríguez-Carrio (University of Oviedo) (@javierrcarrio); (2) Tue Wenzel Kragstrup (University of Aarhus) (@KragstrupTW)

    Más Menos
    17 m
  • Air pollution associated with higher risk of developing autoimmune diseases
    Jun 1 2022
    In this podcast, RMD Open's Social Media Advisor, Dr. Paul Studenic, speaks to Dr. Giovanni Adami, from Universita degli Studi di Verona, Italy, about his population-based cohort study evaluating air pollution-associated risk of developing an immune-mediated disease. By using an Italian-wide patient-dataset, initially designed for fracture risk assessment in women in combination with data for air-quality control stations across Italy, he presents results indicating that long-term exposure to air pollution coincides with a higher risk of developing autoimmune diseases.

    Read it on the RMD Open website: https://rmdopen.bmj.com/content/8/1/e002055

    Más Menos
    19 m
  • COVID-19 and cytokines - same storm, different origins?
    Jun 10 2020
    In this podcast, Caroline Ospelt (Department of Rheumatology, University Hospital of Zurich, Switzerland) talks to Alessia Alunno (Rheumatology Unit, University of Perugia, Italy) about the similarities and differences in the cytokine storm that occurs in COVID-19 patients and people with rheumatic diseases.

    Link to related paper: https://rmdopen.bmj.com/content/6/1/e001295

    Más Menos
    11 m
  • Imaging in large vessel vasculitis
    Nov 9 2018
    A systematic literature review on imaging techniques for diagnosis, outcome prediction and disease monitoring in large vessel vasculitis informing the European League Against Rheumatism recommendations is discussed in this podcast by two of the authors of the paper: Dr. Christina Duftner, rheumatologist at the Medical University Innsbruck, Austria, and Dr. Sofia Ramiro, rheumatologist at Leiden University Medical Center, The Netherlands.

    Read the paper on the RMD Open website: https://rmdopen.bmj.com/content/4/1/e000612.

    Más Menos
    9 m
  • The use of MRI in rheumatology
    Sep 18 2018
    RMD Open Editor-in-Chief Professor Bernard Combe talks to Professor Annette van der Helm from Leiden University Medical Center about the use of MR imaging in the diagnosis and classification of rheumatic and musculoskeletal diseases. Professor van der Helm briefly summarises the pros and cons of MR imaging in comparison with the use of CT images, and highlights some of the technical challenges of this technique.

    For further information on this topic please read this viewpoint article published in RMD Open: https://rmdopen.bmj.com/content/4/1/e000728.

    Más Menos
    3 m
  • Improving the peer review skills of young researchers in rheumatology
    Aug 10 2018
    What is peer-review and why is important? EMEUNET, the Emerging EULAR (European League Against Rheumatism) Network, organises a training program in collaboration with the EULAR journals to improve peer review skills of young researchers. Want to know more? Listen to the conversation between Dr Aurélie Najm (Nantes University Hospital, France) and Dr Javier Rodriìguez-Carrio (Universidad de Oviedo, Spain), first author of “Improving the peer review skills of young rheumatologists and researchers in rheumatology: the EMEUNET Peer Review Mentoring Program”, published by the members of the EMEUNET Peer Mentoring subgroup. Read the full article on the RMD Open website: https://rmdopen.bmj.com/content/4/1/e000619

    Learn more about EMEUNET here: https://emeunet.eular.org

    Más Menos
    11 m